Trial ID or NCT#

NCT03467542

Status

recruiting iconRECRUITING

Purpose

This study is a prospective, multicenter, single-arm study. Patients with Dural Arteriovenous Fistulas (dAVF) have a few choice for safe treatment. In this study, all patients with qualifying dAVFs will be treated with PHIL® Liquid Embolic material.

Official Title

PHIL dAVF: Study of PHIL® Embolic System In The Treatment of Intracranial Dural Arteriovenous Fistulas

Eligibility Criteria

Ages Eligible for Study: 22 Years to 80 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Huy M. Do, MD
Huy M. Do, MD
Interventional neuroradiologist, Radiologist
Professor of Radiology (Neuroimaging and Neurointervention) and, by courtesy, of Neurosurgery and of Otolaryngology - Head & Neck Surgery (OHNS)
Jeremy J. Heit, MD, PhD
Jeremy J. Heit, MD, PhD
Interventional neuroradiologist
Associate Professor of Radiology (Neuroimaging and Neurointervention) and, by courtesy, of Neurosurgery

Contact us to find out if this trial is right for you.

CONTACT

SPECTRUM